Answers are grounded in this paper and cite their sources.
Massively parallel analysis of single immune cells or small immune cell colonies for disease detection, drug screening, and antibody production represents a "killer app" for the rapidly maturing microfabrication and microfluidic technologies. In our view, microfabricated solid-phase and flow cytometry platforms of the future will be complete with biosensors and electrical/mechanical/optical actuators and will enable multi-parametric analysis of cell function, real-time detection of secreted signals, and facile retrieval of cells deemed interesting.
No takes yet. Share an insight, caveat, or question.
Revzin et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: